Back
Amicus Therapeutics Stock Predictions
Marketing's AI Disruption Is Now Secure Your Stake Today!
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
16
FOLD
Amicus Therapeutics
Last Price:
$7.98
Seasonality Move:
3.6%
7 Day Trial
ALL ACCESS PASS
$
7
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Amicus Therapeutics Stock Forecast
-
Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 21.1% based on the past 17 years of stock performance.
-
Amicus Therapeutics has risen higher in 5 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 29.41%
-
Is Amicus Therapeutics Stock Undervalued?The current Amicus Therapeutics [FOLD] share price is $8.16. The Score for FOLD is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
FOLD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Amicus Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 21.1% based on the past 17 years of stock performance.
Amicus Therapeutics Stock Rating
Sell
16
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics overpriced?
-
Amicus Therapeutics has risen higher in 5 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 29.41%
Amicus Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com
52-Week Data
52-Week High:
12.65
52-Week Low:
7.97
Prediction Charts
Market Cap:
2.5B
Price in USD:
8.16
Volume:
4.8M
Beta:
1.01
Technical Analysis
SMA50:
9.26
SMA100:
9.61
SMA200:
10.19
52-Wk Change:
-30.73%
Stock Predictions
-
Is Amicus Therapeutics stock public?Yes, Amicus Therapeutics is a publicly traded company.
-
What is the Amicus Therapeutics stock quote today?The Amicus Therapeutics stock price is 8.16 USD today.
-
How to buy Amicus Therapeutics stock online?You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-12 | 8.87 | 8.89 | 9.00 | 8.80 |
| Mar-13 | 8.94 | 8.81 | 8.94 | 8.73 |
| Mar-14 | 8.87 | 8.90 | 9.00 | 8.79 |
| Mar-17 | 8.93 | 9.12 | 9.12 | 8.85 |
| Mar-18 | 9.11 | 8.98 | 9.17 | 8.97 |
| Mar-19 | 9.04 | 9.20 | 9.24 | 8.99 |
| Mar-20 | 9.11 | 9.08 | 9.26 | 9.07 |
| Mar-21 | 9.00 | 9.01 | 9.19 | 8.93 |
| Mar-24 | 9.07 | 8.69 | 9.08 | 8.63 |
| Mar-25 | 8.70 | 8.62 | 8.71 | 8.52 |
| Mar-26 | 8.63 | 8.52 | 8.67 | 8.40 |
| Mar-27 | 8.54 | 8.59 | 8.60 | 8.49 |
| Mar-28 | 8.61 | 8.43 | 8.62 | 8.36 |
| Mar-31 | 8.31 | 8.16 | 8.31 | 7.97 |
Amicus Therapeutics Earnings
Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Amicus Therapeutics Forecast Revenue Growth
Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.27 per share, and an increase next year of $0.33 per share.
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.